HealthBridge Diagnostics develops portable, AI-powered diagnostic devices that deliver laboratory-grade results in minutes, at the point of care. Their initial product focuses on early detection of [specific disease/condition] using non-invasive methods.

Impact/Key Metrics

• Reduced diagnostic turnaround time from days to minutes.

• Enabled early detection for thousands in rural areas.

• Secured FDA approval for initial device.

• Pilot programs showing 95% accuracy rates.

Why We Invested

HealthBridge Diagnostics is addressing a critical global health disparity with truly disruptive technology. Their potential to democratize access to vital diagnostics and improve patient outcomes resonated deeply with our impact investment goals, combined with a clear path to market and strong IP.